Home/Healthcare/Medical Devices/Antiseptic and Disinfectant Market

Antiseptic and Disinfectant Market - Strategic Insights and Forecasts (2026-2031)

Market Trends, Opportunities & Forecast By Type (Quaternary Ammonium Compounds, Chlorine Compounds, Alcohols & Aldehyde Products, Enzyme, Others), By Product (Enzymatic Cleaners, Medical Device Disinfectants, Surface Disinfectants), By End-User (Hospitals, Clinics, Others), and Geography

$3,950
Single User License

Report Overview

Antiseptic And Disinfectant Market, growing at a 5.9% CAGR, is expected to grow to USD 58.4 billion in 2031 from USD 41.5 billion in 2025.

Market Growth Projection (CAGR: 5.9%)
$41.50B
2025
$43.93B
2026
$58.40B
2031
Antiseptic and Disinfectant Market Highlights
Rising demand for alcohol-based disinfectants is driving widespread adoption in clinical settings.
Healthcare facilities are increasingly using antiseptics to combat hospital-acquired infections (HAIs).
Manufacturers are investing heavily in R&D to develop advanced antiseptic and disinfectant solutions.
Insurance providers are offering reimbursement policies, making disinfectant treatments more accessible globally.

Antiseptics are used in healthcare facilities for a wide range of topical and hard-surface applications. In contrast to antibiotics, the majority of these active compounds have broad-spectrum antimicrobial activity, although little is known about their method of action. Since antiseptics and disinfectants are used widely, there has been significant discussion over the emergence of microbial resistance, particularly about whether antimicrobial resistance is brought on by antiseptics or disinfectants.

Antiseptic and Disinfectant Market Growth Drivers:

  • Growth drivers fueling the antiseptic and disinfectant market

Rising instances of illness caused due to infections are a major growth driver for the antiseptic and disinfectant market. Precautions must be taken by people as the population around the world is prone to illness caused by infections. Extensive R&D programs are being carried out by industry leaders to manufacture new and improved products, which is propelling the antiseptic and disinfectant market share. The growing investment by these manufacturers has also emerged as a crucial factor for the antiseptic and disinfectant market growth.

  • Rising incidence of HAIs

One of the main drivers of antiseptic and disinfectant market expansion is the rising prevalence of HAIs brought on by a lack of sanitation and safety measures. For instance, Healthcare-Associated Infections estimated that at least one HAI occurs annually in approximately one in every twenty-five patients present in the hospital. Antiseptics and disinfectants play a significant role in overall contamination prevention and lowering the frequency of HAIs. Antiseptic and disinfectant products protect the patient's body from any bacterial and microbial infections, which is further propelling the antiseptic and disinfectant market.

  • Multiple reimbursement policies are a major growth opportunity

Many attractive reimbursement plans are being offered by insurance firms to customers that would help them select cutting-edge technologies for treatment, leading to antiseptic and disinfectant market growth. Reimbursement strategies are encouraged to make treatment options accessible for these people despite their low disposable income. As the number of people suffering from infectious illnesses increases, the number of reimbursements that are being authorized also increases.

  • Surface disinfectants are showing growth potential

Chemical substances known as surface disinfectants are used to kill or render inactive bacteria on inert surfaces. These disinfectants function by rupturing microorganisms' cell walls or obstructing their metabolism. Infections that do not exist or are not incubating at the time a patient is admitted can be avoided by performing thorough surface cleaning. Surface disinfectants utilize several chemicals for various objectives. In non-healthcare contexts, sodium hypochlorite (bleach/chlorine) may be used at a recommended dosage of 0.1% or 1,000 ppm, according to World Health Organisation (WHO) data revised in March 2022. Also useful for surface sanitation is alcohol at 70–90% concentration.

  • Medical device disinfectants are anticipated to grow significantly

Surgical units and endoscopes are often reprocessed using medical equipment disinfectants. Phenol, hydrogen peroxide, peracetic acid, and glutaraldehyde are some of the disinfectants used for reprocessing or disinfecting medical devices. The risk of infection spreading from patient to patient due to skin contact is the reason why endoscopes and medical devices need to be disinfected. The rising number of surgical operations being performed globally is one of the primary factors propelling the antiseptic and disinfectant market growth.

  • Increasing demand for alcohol-based disinfectants

Alcohol-based disinfectants are utilized on clinical instruments due to their effectiveness in eliminating a wide variety of bacteria. They are ideal for medical applications because they are also simple to use and non-toxic. Disinfecting endoscopes is one of the main uses for clinical equipment. Endoscopes are often sterilized and cleaned using alcohol-based disinfectants. They efficiently eradicate many germs, including fungi, bacteria, and viruses. Thus, the growing need for alcohol-based disinfectants for medical equipment will probably promote antiseptic and disinfectant market expansion.

Antiseptic and Disinfectant Market Geographical Outlook:

  • North America is anticipated to be the largest glaucoma market shareholder

North America is predicted to be the leading antiseptic and disinfectant market shareholder due to the increasing number of healthcare personnel working in North America and the growing number of operations, the demand for disinfectants and antiseptics in the region is anticipated to increase. Antiseptic and disinfection treatments are crucial for surgical procedures and scientific research because they minimize the danger of infection and contamination transferring from one patient to another. Furthermore, the region is experiencing growth due to a rise in the incidence of hospital-acquired infections and the adoption of doctor-prescribed infection therapies.

Antiseptic and Disinfectant Market - Products Offering:

Based on the level of protection necessary for various occupational hazards, antiseptics and disinfectant manufacturing businesses utilize novel and cutting-edge technologies to create, manufacture, and distribute goods to a variety of end consumers, which is crucial in the expansion of antiseptic and disinfectant market share. For instance, Health Canada added five SC Johnson household cleaning products to its list of effective disinfectants for use against SARS-CoV-2 in January 2021. These disinfectants have been authorized by SC Johnson to destroy SARS-CoV-2, the virus that generates COVID-19 symptoms like bubbles when you scrub. The COVID-19 pandemic, therefore, had a favourable commercial impact as a result of previous and ongoing developments made by numerous firms.

Antiseptic and Disinfectant Market Key Developments:

  • In October 2022, Cororid disinfection products were introduced by Deepak Fertilisers And Petrochemicals Corporation (DFPCL) to meet the unique requirements of hospitals, clinics, labs, and other medical and healthcare setups.

  • In September 2022, Reckitt and its brand Dettol announced a partnership with delivery service and local travel leaders Deliveroo, SF Express, and Uber to safeguard the daily needs of Hong Kong residents by enhancing the hygiene standards of their services with visible disinfectants.

  • In August 2022, PDI announced the dual introduction of unique, innovative disinfectants to aid infection prevention experts in the ongoing fight against COVID-19 and the growing number of healthcare-associated infections (HAIs).

Antiseptic and Disinfectant Market Scope:

Report Metric Details
Total Market Size in 2025 USD 41.5 billion
Total Market Size in 2031 USD 58.4 billion
Forecast Unit Billion
Growth Rate 5.9%
Study Period 2020 to 2031
Historical Data 2020 to 2023
Base Year 2024
Forecast Period 2025 – 2031
Segmentation Type, Product, End-User, Geography
Companies
  • PSK Pharma
  • ACTO GmbH
  • Dr. Schumacher GmbH
  • Reckitt Benckiser
  • Steris Plc

Market Segmentation

By Type

Quaternary Ammonium Compounds
Chlorine Compounds
Alcohols & Aldehyde Products
Enzyme
Others

By Product

Enzymatic Cleaners
Medical Device Disinfectants
Surface Disinfectants

By End-user

Hospitals
Clinics
Others

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others

Table of Contents

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. ANTISEPTIC AND DISINFECTANT MARKET BY TYPE

5.1. Introduction

5.2. Quaternary Ammonium Compounds

5.3. Chlorine Compounds

5.4. Alcohols & Aldehyde Products

5.5. Enzyme

5.6. Others

6. ANTISEPTIC AND DISINFECTANT MARKET BY PRODUCT

6.1. Introduction

6.2. Enzymatic Cleaners

6.3. Medical Device Disinfectants

6.4. Surface Disinfectants

7. ANTISEPTIC AND DISINFECTANT MARKET BY END-USER

7.1. Introduction

7.2. Hospitals

7.3. Clinics

7.4. Others

8. ANTISEPTIC AND DISINFECTANT  MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. USA

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. Germany

8.4.2. France

8.4.3. United Kingdom

8.4.4. Spain

8.4.5. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Others

8.6. Asia Pacific

8.6.1. China

8.6.2. India

8.6.3. Japan

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. PSK Pharma

10.2. ACTO GmbH

10.3. Dr. Schumacher GmbH

10.4. 3M

10.5. Reckitt Benckiser

10.6. Steris Plc

10.7. Kimberly-Clark Corporation

10.8. Cardinal Health

10.9. BD

11. APPENDIX

11.1. Currency 

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key benefits for the stakeholders

11.5. Research Methodology 

11.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES

Request Customization

Tell us your specific requirements and we will customize this report for you.

πŸ“ž

Your data is secure. We do not share information with any third party.

Download Free Sample

Get a sample copy of this report with charts, TOC, and methodology.

πŸ“ž

Your data is secure. We do not share information with any third party.

Speak to Analyst

Ask our analysts any questions you have about this market research report.

πŸ“ž

Your data is secure. We do not share information with any third party.

Antiseptic and Disinfectant Market Report

Report IDKSI061615753
PublishedJan 2026
Pages148
FormatPDF, Excel, PPT, Dashboard

Need Assistance?

Our research team is available to answer your questions.

Contact Us
Frequently Asked Questions

The Antiseptic and Disinfectant Market is forecast to grow at a 5.9% CAGR. It is expected to reach USD 58.4 billion by 2031, significantly up from USD 41.5 billion in 2025, indicating robust expansion driven by increasing global demand.

The market is experiencing rising demand for alcohol-based disinfectants, leading to widespread adoption in clinical settings. Furthermore, antiseptics are extensively utilized in healthcare facilities for both topical and hard-surface applications, playing a critical role in combating hospital-acquired infections (HAIs).

Primary growth drivers include the rising global incidence of illnesses caused by infections and the increasing prevalence of Hospital-Acquired Infections (HAIs). Extensive R&D programs by industry leaders to manufacture new and improved products, along with supportive reimbursement policies, are also significantly propelling market growth.

The report identifies multiple attractive reimbursement policies offered by insurance firms as a major growth opportunity, enhancing accessibility to cutting-edge disinfectant treatments globally. Additionally, sustained investment by manufacturers in R&D to develop advanced solutions continues to create significant market opportunities.

Manufacturers are actively contributing through heavy investments in R&D programs, focused on developing advanced antiseptic and disinfectant solutions. These efforts result in new and improved products, which are crucial for addressing rising demand and increasing the market share for antiseptic and disinfectant solutions.

The report highlights significant discussion around the emergence of microbial resistance due to the widespread use of antiseptics and disinfectants. While these compounds offer broad-spectrum antimicrobial activity, the potential for developing antimicrobial resistance is a key concern and an area of ongoing scrutiny within the industry.

Need data specifically for your business?Request Custom Research β†’
Related Reports

Trusted by the world's leading organizations

Weber Shandwick
veolia
Tri
tls
TeamViewer
GE Healthcare
Intel
Proctor and Gamble
ABB
Elkem
Defense Logistics Agency
Amazon